AKR1B1 and diabetic retinopathy: Recently, aldose reductase inhibitors have been found to have potentanti-inflammatory actions, even in normoglycemia[144–146, 177].The possibility that reported beneficial effects of aldose reductase inhibitors on diabetic retinopathy were due,instead, to anti-inflammatory actions has not yet been studied.